(1)
The Assessment Of The Complementary Chemotherapeutic Potential Of Nigella Sativa In Patients With Colorectal Cancer: A Randomized Clinical Trial. Journal of Pharmaceutical Negative Results 2023, 635-643. https://doi.org/10.47750/pnr.2023.14.04.76.